I have just come across this document:
Big Drug's Nicotine War
http://www.forces.org/evidence/pharma/pdf/fullwork.pdf
very long - and very informative
I admit that I have not read the whole thing yet. But I thought I'd share it with you.
If this is the wrong sub-forum, please move it. I did not know where to put it, to be honest.
Big Drug's Nicotine War
http://www.forces.org/evidence/pharma/pdf/fullwork.pdf
very long - and very informative
I am pleased to announce a new partnership here today. We have just set up a Partnership
Project in our European Region, with the objective of reducing tobacco-related death and disease
among smokers . Three major pharmaceutical companies have joined this partnership: Glaxo
Wellcome, Novartis, and Pharmacia & Upjohn. They all manufacture treatment products against
tobacco dependence.
- Gro Harlem Brundtland, Director-General of the World Health Organization, Speech delivered at The
World Economic Forum, Davos, Switzerland, Jan. 30, 1999.
A second and more serious problem is economic ties between NIH [National Institutes of Health]
researchers and big drug companies, which some critics charge amount to payoffs. Earlier this
week, for example, a Times report showed how the agencys top diabetes researcher was accepting
payments from at least four pharmaceutical companies that stood to gain from NIH research he
directed, a clear ethics violation.
There are also more subtle conflicts. The NIHs cliquish peer reviewers are often elite
university researchers who may favor studies that, by proving the effectiveness of brand-name
pharmaceutical drugs, bring in loads of drug company grant money for their academic
departments.
(Flap Over Public Science, Los Angeles Times, 1/30/99)
The CDCs 1996 Tobacco Use Prevention Program: At-A-Glance listed among its Key Partners The
Robert Wood Johnson Foundation and the RWJF-funded National Center for Tobacco-Free Kids. However,
its involvement with the pharmaceutical and addiction industries goes at least as far back as the 1988
Surgeon Generals report, The Health Consequences of Smoking: Nicotine Addiction, which changed the
very definition of addiction in order to include tobacco use and which emphasized that smoking was an
addiction to be treated with pharmacological products and counseling.
Though most people are not aware of it, the Surgeon Generals reports on smoking and health are not
actually written by the Surgeon General but by a number of authors, some of whom are employees of the
CDC and some of whom are selected experts from the private sector. The 1988 report was prepared under
the general editorship of Ron Davis, who was then Director of the CDCs Office on Smoking and Health, but
many others were involved in scientific editing and writing of the report. One of the scientific editors was
Jack Henningfield, who was then at the National Institute on Drug Abuse, but who later became one of the
associates at Pinney Associates and a consultant to Glaxo Wellcome. At least some of the outside experts
stood to gain financially from the report. Many of these were in the addiction business. One of the writers
was Jed Rose, who had invented the nicotine patch in the early 1980s and had sold marketing and production
rights for the patch to the pharmaceutical industry. Another was C. Tracy Orleans, who would become an
employee of the Robert Wood Johnson Foundation, and others, such as Michael Fiore, Saul Shiffman and
Richard Clayton, would parlay their participation into consultantships and research grants from the
pharmaceutical industry, the RWJF, and the federal government.
[A] recent study by USA Today revealed that more than half of the advisors to the Food and
Drug Administration (FDA) have financial relationships with pharmaceutical companies that
have an interest in FDA decisions.
Catherine DeAngelis, Conflict of Interest and the Public Trust, Journal of the American Medical
Association, 284(17), Nov 1, 2000.
.If members of our society were empowered to make their own decisions then the whole
rationale for the [FDA] would cease to exist.
David Kessler. Quoted in James Bovard, First Step To an FDA Cure: Dump Kessler, The Wall St.
Journal, 12/8/94
I admit that I have not read the whole thing yet. But I thought I'd share it with you.
If this is the wrong sub-forum, please move it. I did not know where to put it, to be honest.